Scenario name,Rate of gonorrhea cases,"% cases successfully treated with CIP, TET, or CRO",% cases susceptible to CIP,% cases susceptible to TET,% cases susceptible to CRO,"Effective lifespan of CIP, TET, and CRO",Effective lifespan of CIP,Effective lifespan of TET,Effective lifespan of CRO,delta - Rate of gonorrhea cases,"delta - Effective lifespan of CIP, TET, and CRO",delta - Effective lifespan of CIP,delta - Effective lifespan of TET,delta - Effective lifespan of CRO
Status quo (no rapid test),"6,602 (5,175, 7,851)","49.1% (33.8%, 63.3%)","72.2% (56.9%, 87.3%)","17.8% (12.0%, 26.2%)","95.2% (91.6%, 96.8%)","12.3 (8.5, 15.8)","18.1 (14.2, 21.8)","4.5 (3.0, 6.5)","23.8 (22.9, 24.2)",,,,,
"(p=None, None), q=(None, None), c=0.500)","6,861 (5,410, 8,246)","60.0% (39.6%, 81.0%)","68.0% (51.2%, 83.4%)","16.2% (10.6%, 24.1%)","96.3% (93.3%, 98.1%)","15.0 (9.9, 20.3)","17.0 (12.8, 20.9)","4.0 (2.7, 6.0)","24.1 (23.3, 24.5)","4.0% (0.6%, 8.9%)","22.6% (4.2%, 49.9%)","-6.0% (-10.2%, -2.6%)","-9.4% (-16.7%, -2.7%)","1.1% (-1.2%, 3.4%)"
"(p=None, None), q=(None, None), c=0.750)","7,030 (5,549, 8,565)","61.4% (39.6%, 85.1%)","66.7% (48.4%, 82.5%)","15.6% (10.3%, 23.0%)","96.3% (92.8%, 98.1%)","15.3 (9.9, 21.3)","16.7 (12.1, 20.6)","3.9 (2.6, 5.7)","24.1 (23.2, 24.5)","6.5% (1.9%, 12.8%)","25.5% (4.2%, 57.1%)","-7.9% (-14.7%, -4.1%)","-12.7% (-21.4%, -6.0%)","1.2% (-1.4%, 4.0%)"
"(p=None, None), q=(None, None), c=1.000)","7,216 (5,739, 8,866)","61.9% (39.6%, 83.6%)","65.5% (47.1%, 82.1%)","15.0% (9.8%, 22.5%)","96.2% (92.7%, 98.2%)","15.5 (9.9, 20.9)","16.4 (11.8, 20.5)","3.8 (2.5, 5.6)","24.1 (23.2, 24.5)","9.3% (3.6%, 17.8%)","26.8% (7.0%, 52.1%)","-9.6% (-17.4%, -4.3%)","-16.1% (-25.3%, -7.0%)","1.1% (-1.2%, 3.6%)"
